glp-1 and migraines glp 1 Drug Cuts Migraine Days in Half A new study finds that Study finds GLP-1 drug cut
Description
Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV study
Clinicians must be vigilant and monitor this potentially serious adverse event
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al
CrossRef Sex differences and sex steroids influence on the presentation and severity of cardiovascular autonomic neuropathy of patients with type 1 diabetes La Nattero-Chvez, Mara Insenser, Alejandra Quintero Tobar, Elena Fernndez-Durn, Beatriz Dorado Avendao, Tom Fiers, Jean-Marc Kaufman, Manuel Luque-Ramrez, Hctor F
Understanding how to maintain weight loss after tirzepatide is critical for long-term planning
And the weight loss numbers, while impressive for both, tell very different stories when you look beneath the surface
